川宁生物：合成生物学产品2025年前三季度整体收入已达到4880万元

Core Viewpoint - Chuaning Biological announced that its synthetic biology product revenue reached 48.8 million yuan in the first three quarters of 2025, indicating a positive trend in order improvement compared to the same period last year [1] Group 1: Financial Performance - The overall revenue from synthetic biology products for the first three quarters of 2025 has reached 48.8 million yuan [1] - The company expects significant revenue improvement in synthetic biology products next year as production capacity increases and market expansion continues [1] Group 2: Market Development - The company's marketing department has actively developed the market, leading to improved order conditions compared to the previous year [1] - New products are currently in production, contributing to the positive outlook for revenue growth [1]